Researchers have shown for the first time how mutations affecting a cellular process called RNA splicing alter cells to develop myelodysplastic syndrome (MDS) and other hematologic malignancies and solid tumors.
Click here for original story, Researchers identify new drug target for blood cancer, potentially solid tumors
Source: ScienceDaily